BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 50 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $628 | +27.9% | 43,557 | +45.8% | 0.00% | +50.0% |
| Q2 2023 | $491 | +20.9% | 29,874 | +23.1% | 0.00% | 0.0% |
| Q1 2023 | $406 | +19.8% | 24,277 | +10.4% | 0.00% | 0.0% |
| Q4 2022 | $339 | -99.9% | 21,999 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $325,000 | -22.6% | 21,735 | -14.9% | 0.00% | 0.0% |
| Q2 2022 | $420,000 | -10.8% | 25,549 | +8.8% | 0.00% | 0.0% |
| Q1 2022 | $471,000 | +8.8% | 23,480 | +37.5% | 0.00% | 0.0% |
| Q4 2021 | $433,000 | -57.7% | 17,073 | -55.0% | 0.00% | -60.0% |
| Q3 2021 | $1,023,000 | -2.8% | 37,929 | +4.2% | 0.01% | 0.0% |
| Q2 2021 | $1,053,000 | +21.0% | 36,394 | +10.1% | 0.01% | 0.0% |
| Q1 2021 | $870,000 | +23.1% | 33,069 | +33.9% | 0.01% | +25.0% |
| Q4 2020 | $707,000 | +75.9% | 24,692 | +46.4% | 0.00% | +33.3% |
| Q3 2020 | $402,000 | +55.2% | 16,867 | +36.1% | 0.00% | +50.0% |
| Q2 2020 | $259,000 | – | 12,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ PARTNERS, LLC | 174,942 | $3,509,000 | 1.89% |
| Logan Stone Capital, LLC | 81,077 | $1,626,000 | 1.17% |
| Nova R Wealth, Inc. | 39,657 | $796,000 | 0.68% |
| Cornerstone Advisors, LLC | 501,100 | $10,052,000 | 0.59% |
| 1607 Capital Partners, LLC | 358,024 | $7,182,000 | 0.42% |
| Quantedge Capital Pte Ltd | 69,600 | $1,396,000 | 0.41% |
| SENTINEL TRUST CO LBA | 163,567 | $3,281,000 | 0.39% |
| KAVAR CAPITAL PARTNERS GROUP, LLC | 69,000 | $1,384,000 | 0.30% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 218,424 | $4,376,000 | 0.28% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 93,165 | $1,869,000 | 0.24% |